Application of genistein in preparation of heavy ion radiation-sensitizing drug
A technology of genistein and heavy ion radiation, applied in the field of biomedicine, to achieve the effect of reducing the number of treatments, reducing the cost of treatment, and improving the killing efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0032] 1. Cells and Reagents
[0033] M059K and U87 are radiation-resistant human glioma cells, originally purchased from the ATCC cell bank in the United States, and then cultured and stored in our laboratory; DMEM / F12 and DMEM medium were purchased from Gibco; fetal bovine serum (FBS) was purchased from Corning; Genistein and Nu7026 were purchased from Sigma; and biochemical reagents such as dimethyl sulfoxide (DMSO) and Triton X-100 were purchased from Gansu Pengcheng Biotechnology Development Co., Ltd. Using the high energy of the Institute of Modern Physics, Chinese Academy of Sciences 12 C 6+ The heavy ion beam is used as the radiation source to irradiate the experimental materials.
[0034] experimental method
[0035] 2.1 Cell culture and drug treatment
[0036] Human glioma M059K and U87 cells were cultured in a complete medium containing 10% FBS in DMEM / F12 and DMEM, respectively, in a 5% carbon dioxide, 37°C saturated humidity incubator, and the logarithmic growth phase ce...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com